Behringwerke AG
Records under this name other than the patents Behringwerke AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,220,556 | Preparation of factor XIIIa by gene manipulation Formerly held Term ended Term ended May 22, 2024 · From the USPTO record | Term ended | Term ended May 22, 2024 | From the USPTO record |
| US 7,029,856 | Methods for determination of an analyte Formerly held Term ended Term ended Apr 18, 2023 · From the USPTO record | Term ended | Term ended Apr 18, 2023 | From the USPTO record |
| US 6,746,866 | Preparation of factor XIIIa by gene manipulation Formerly held Term ended Ended no later than Jun 8, 2021 · From the USPTO record | Term ended | Ended no later than Jun 8, 2021 | From the USPTO record |
| US 6,733,989 | Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), the preparation and use thereof Formerly held Term ended Term ended May 11, 2021 · From the USPTO record | Term ended | Term ended May 11, 2021 | From the USPTO record |
| US 6,566,085 | Synthetic peptides, antibodies directed against them, and the use thereof Formerly held Term ended Term ended May 20, 2020 · From the USPTO record | Term ended | Term ended May 20, 2020 | From the USPTO record |
| US 6,538,113 | Methods of obtaining antibody directed against prothrombin fragments F2/F1+2 Formerly held Term ended Term ended Mar 25, 2020 · From the USPTO record | Term ended | Term ended Mar 25, 2020 | From the USPTO record |
| US 6,455,288 | Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases Formerly held Term ended Term ended Sep 24, 2019 · From the USPTO record | Term ended | Term ended Sep 24, 2019 | From the USPTO record |
| US 6,328,954 | Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections Formerly held Term ended Term ended Jul 29, 2019 · From the USPTO record | Term ended | Term ended Jul 29, 2019 | From the USPTO record |
| US 6,406,913 | Assay method utilizing induced luminescence Formerly held Term ended Term ended Jun 18, 2019 · From the USPTO record | Term ended | Term ended Jun 18, 2019 | From the USPTO record |
| US 6,326,159 | Receptors for immune complexes Formerly held Term ended Term ended Dec 4, 2018 · From the USPTO record | Term ended | Term ended Dec 4, 2018 | From the USPTO record |